These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

840 related items for PubMed ID: 9344188

  • 1. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [Abstract] [Full Text] [Related]

  • 2. Vitamin D and systemic therapy.
    van de Kerkhof P.
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [Abstract] [Full Text] [Related]

  • 3. Calcipotriol/calcipotriene (Dovonex/Daivonex) in combination with phototherapy: a review.
    Koo J.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S59-61. PubMed ID: 9344187
    [Abstract] [Full Text] [Related]

  • 4. Childhood psoriasis: often favorable outcome.
    Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
    [Abstract] [Full Text] [Related]

  • 5. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P, Yentzer BA, Dabade TS, Feldman SR.
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [Abstract] [Full Text] [Related]

  • 6. Topical calcipotriene ointment and etretinate: another combination therapy for psoriasis vulgaris.
    Vázquez-López F, Pérez-Oliva N, Hernandez-Mejia R.
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):803. PubMed ID: 9146555
    [No Abstract] [Full Text] [Related]

  • 7. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [Abstract] [Full Text] [Related]

  • 8. [Psoriasis].
    Guilhou JJ, Girard C.
    Rev Prat; 2006 Dec 15; 56(19):2153-8. PubMed ID: 17416055
    [No Abstract] [Full Text] [Related]

  • 9. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
    Tirado-Sánchez A, Ponce-Olivera RM.
    Cutis; 2012 Sep 15; 90(3):140-4. PubMed ID: 23094314
    [Abstract] [Full Text] [Related]

  • 10. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A, Coppini M, Bertazzoni MG, Califano A, Altieri E, Pazzaglia A, Lega M, Lombardo M, Pelfini C, Veller Fornasa C, Rabbiosi G, Cespa M.
    J Eur Acad Dermatol Venereol; 1999 Sep 15; 13(2):91-5. PubMed ID: 10568486
    [Abstract] [Full Text] [Related]

  • 11. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M.
    J Am Acad Dermatol; 1997 Sep 15; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [Abstract] [Full Text] [Related]

  • 12. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA.
    J Am Acad Dermatol; 1997 Sep 15; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [Abstract] [Full Text] [Related]

  • 13. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
    Maryles S, Rozenblit M, Lebwohl M.
    J Dermatolog Treat; 2003 Sep 15; 14 Suppl 2():7-16. PubMed ID: 14578093
    [Abstract] [Full Text] [Related]

  • 14. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.
    Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE.
    Arch Dermatol; 2000 Dec 15; 136(12):1536-43. PubMed ID: 11115167
    [Abstract] [Full Text] [Related]

  • 15. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A, Abramovits W, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2009 Jan 15; 8(1):52-7. PubMed ID: 19180896
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D and topical therapy.
    Lebwohl M.
    Cutis; 2002 Nov 15; 70(5 Suppl):5-8. PubMed ID: 12467332
    [Abstract] [Full Text] [Related]

  • 17. Current systemic therapies for psoriasis: where are we now?
    Yamauchi PS, Rizk D, Kormeili T, Patnaik R, Lowe NJ.
    J Am Acad Dermatol; 2003 Aug 15; 49(2 Suppl):S66-77. PubMed ID: 12894129
    [Abstract] [Full Text] [Related]

  • 18. Psoriasis treatment in the United States at the end of the 20th century.
    Pearce DJ, Stealey KH, Balkrishnan R, Fleischer AB, Feldman SR.
    Int J Dermatol; 2006 Apr 15; 45(4):370-4. PubMed ID: 16650160
    [Abstract] [Full Text] [Related]

  • 19. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W.
    J Drugs Dermatol; 2009 Aug 15; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [Abstract] [Full Text] [Related]

  • 20. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.
    Koo J, Blum RR, Lebwohl M.
    J Am Acad Dermatol; 2006 Oct 15; 55(4):637-41. PubMed ID: 17010744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.